Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Caprion, Vertex Enter Biomarker Discovery Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Caprion, Vertex Enter Biomarker Discovery Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Caprion Pharmaceuticals’ Applied BioMedicine group has entered a research collaboration with Vertex Pharmaceuticals. The collaboration will use Caprion’s CellCarta proteomics platform to support clinical biomarker discovery. Caprion will identify potential pharmacodynamic biomarkers in samples from certain clinical and preclinical studies conducted by Vertex.

“Caprion is looking forward to working with Vertex on this clinical biomarker discovery collaboration,” said Dr. Daniel Chelsky, chief scientific officer at Caprion. “We believe that Caprion’s capabilities in the discovery of protein biomarkers may significantly impact development efforts for one or more Vertex compounds.”

Caprion’s proprietary proteomics platform comprehensively profiles proteins and provides an unprecedented level of protein expression and identification in tissues and blood plasma. Caprion is presently conducting biomarker discovery programs in other indications for several pharmaceutical and biotechnology companies and its own clinical programs.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters